Appendix D

Registered Attendees

Adetayo Adewolu

Prince George’s County Health Department

Kris Anderson


Katrina Armstrong

University of Pennsylvania

Naomi Aronson

Blue Cross and Blue Shield Association

Euan Ashley

Stanford University

Eric Assaraf


Carlos Avila

Abt Associates

Erin Balogh

Institute of Medicine

Arthur Beaudet

Baylor College of Medicine

Paul Billings

Life Technologies

Gregory Bloss

National Institute on Alcohol Abuse and Alcoholism

Bruce Blumberg

Kaiser Permanente

Juli Bollinger

Johns Hopkins University

Denise Bonds

National Heart, Lung, and Blood Institute

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 101
Appendix D Registered Attendees Adetayo Adewolu Erin Balogh Prince George’s County Health Institute of Medicine Department Arthur Beaudet Kris Anderson Baylor College of Medicine Freelance Paul Billings Katrina Armstrong Life Technologies University of Pennsylvania Gregory Bloss Naomi Aronson National Institute on Alcohol Blue Cross and Blue Shield Abuse and Alcoholism Association Bruce Blumberg Euan Ashley Kaiser Permanente Stanford University Juli Bollinger Eric Assaraf Johns Hopkins University WRG Denise Bonds Carlos Avila National Heart, Lung, and Blood Abt Associates Institute 101

OCR for page 101
102 THE ECONOMICS OF GENOMIC MEDICINE Vence Bonham Erin Cole National Human Genome Research Mayo Clinic Institute Richard Conroy Joann Boughman National Institutes of Health American Society of Human Genetics Sara Copeland Health Resources and Services Jen Bowman Administration American Clinical Laboratory Association Cecilia Copperman Genetic Alliance Pamela Bradley American Association for Cancer Jeff Cossman Research United States Diagnostics Standards, Inc. Kenneth Brigham Emory University Claude Desjardins Johns Hopkins University Stacye Bruckbauer FasterCures Patricia Deverka Center for Medical Technology Wylie Burke Policy University of Washington Noel Doheny Ned Calonge Epigenomics, Inc. The Colorado Trust Siobhan Dolan Sarah Carter Albert Einstein College of J. Craig Venter Institute Medicine/Montefiore Medical Center C. Thomas Caskey Baylor College of Medicine Maria DeTolve Donoghue G&M Consulting Services Lon Castle Express Scripts Subash Duggirala Centers for Medicare & Medicaid Frederick Chen Services University of Washington Victor Dzau Melina Cimler Duke University Health System Illumina

OCR for page 101
APPENDIX D 103 Peggy Eastman Geoffrey Ginsburg Oncology Times Duke University, Institute for Genome Sciences and Policy Stephen Eck Astellas Pamela Goetz National Coalition for Cancer Matt Elrod Survivorship American Physical Therapy Association Jeanne Gorman JMG Associates Rebecca English Institute of Medicine Scott Grosse Centers for Disease Control and Raith Erickson Prevention Complete Genomics John Haaga James Evans National Institute on Aging University of North Carolina at Chapel Hill Evan Hadley National Institute on Aging W. Gregory Feero National Human Genome Research Kelly Haenlein Institute Genentech J. Michael Fitzmaurice Chris Havasy Agency for Healthcare Research Presidential Commission for the and Quality Study of Bioethical Issues Heather Tollerson Flannery Kristy Hawley Obesity PPM American Medical Association Mark Fleury Richard Heimler American Association for Cancer Patient Research C. J. Hoban Andrew Freedman Multiple Myeloma Research National Cancer Institute Foundation Michelle Gilats India Hook-Barnard Chicago Center for Jewish Genetics National Academy of Sciences

OCR for page 101
104 THE ECONOMICS OF GENOMIC MEDICINE Gillian Hooker Muin Khoury National Human Genome Research Centers for Disease Control and Institute Prevention Kathi Huddleston Roger Klein Inova Translational Medicine University of South Florida School Institute of Medicine Jean Jenkins John Lauerman National Human Genome Research Bloomberg News Institute Thomas Lehner Janet Jenkins-Showalter National Institute of Mental Roche/Genentech Health Irene Jillson Jennifer Leib Georgetown University HealthFutures, LLC Heajin Jung Debra Leonard Heajin Jung Law Firm Weill Cornell Medical College Francis Kalush Laura Levit U.S. Food and Drug Institute of Medicine Administration Timothy Ley Jeffrey Kant Washington University University of Pittsburgh Medical Center Jeffrey Lin Johns Hopkins University Applied Sharon Kardia Physics Laboratory University of Michigan Stephen Lincoln David Kaufman InVitae/Genomic Health Genetics and Public Policy Center Nicole Littmann Rebecca Kelly Quorum Consulting American College of Cardiology Michele Lloyd-Puryear Mohamed Khan Office of Rare Diseases Research, British Columbia Cancer Agency National Institutes of Health

OCR for page 101
APPENDIX D 105 Jenny Luray Jennifer Moser BD U.S. Department of Veterans Affairs Julie Lynch U.S. Department of Veterans Sharon Murphy Affairs Institute of Medicine Elizabeth Mansfield Marc Newman Office of In Vitro Diagnostics and TeleCenter Radiological Health, U.S. Food and Drug Administration Robert Nussbaum University of California, San Gary Marchant Francisco Arizona State University Kenneth Offit Saralyn Mark Memorial Sloan-Kettering Cancer NASA Center Priscilla Markwood Lydia Pan Association of Pathology Chairs Pfizer Inc. Robert McCormack Herbert Pardes Veridex, LLC New York–Presbyterian Hospital Scott McGoohan Meeta Patnaik American Clinical Laboratory Transtek Clinical Systems, Inc. Association Michelle Penny Kathryn McLaughlin Eli Lilly and Company Health Resources and Services Administration Aidan Power Pfizer Inc. Brian McTigue Partners Healthcare Victoria Pratt Quest Diagnostics Kala Menon Booz Allen Hamilton Oscar Puig Roche Douglas C. Monroe Kaiser Permanente Bruce Quinn Foley Hoag LLP

OCR for page 101
106 THE ECONOMICS OF GENOMIC MEDICINE Scott Ramsey Cecili Sessions Fred Hutchinson Cancer Research Air Force Medical Support Agency Center Paul Sheives Kate Reed Biotechnology Industry National Coalition for Health Organization Professional Education in Genetics Leah Silva Genetic Alliance John Reppas Neurotechnology Industry Tania Simoncelli Organization Office of Medical Products and Tobacco, U.S. Food and Drug Steven Richardson Administration Genomic Health, Inc. Naoko Simonds Denise Robinson National Cancer Institute bioTheranostics, Inc. Mary Lou Smith Allen Roses Research Advocacy Network Duke University James Sorace Julie Sakowski U.S. Department of Health and University of California, San Human Services Francisco Noemie Sportiche Carol Sardinha U.S. Department of Health and CAS Healthcare Associates Human Services Mari Savickis Tamara Stuchlak American Medical Association Air Force Medical Support Agency Derek Scholes Jayson Swanson National Human Genome Research Genetic Alliance Institute Katie Johansen Taber Joan Scott American Medical Association National Coalition for Health Professional Education in Sharon Terry Genetics Genetic Alliance

OCR for page 101
APPENDIX D 107 Tamar Thompson David Wierz Kimbell & Associates OCI, LLC Kuo Tong Wendy Wifler QUORUM Consulting Agendia Inc. David Veenstra Mara Wilber University of Washington Genetic Alliance Xiaobin Wang Erin Wilhelm Johns Hopkins Bloomberg School Georgetown University of Public Health Marc Williams Michael Watson Geisinger Health System American College of Medical Genetics and Genomics Mary Williams Association for Molecular Meredith Weaver Pathology American College of Medical Genetics and Genomics Stephen Williams Marwood Group Lale White XIFIN, Inc. Martin Willie Universal Genomic Systems, Inc. Ross White The Hastings Center Rina Wolf XIFIN, Inc. Catherine Wicklund Northwestern University Marta Wosinska U.S. Food and Drug Jacqueline Wieneke Administration U.S. Food and Drug Administration

OCR for page 101